Substance Use

For 340B-covered entities, core to the challenge of navigating a changing and uncertain policy landscape is the complexity of how multiple variables interact differently with each covered health care entity based on its unique makeup of services, funding, patient population, and payer mix. This toolkit aims to assist 340B covered entities in understanding their current areas of funding stability and where they are vulnerable, and to plan for the future.

Read More
Substance Use
Navigating changes to the 340B drug pricing program: a toolkit for HIV-related healthcare entities in California

October 4, 2024

In light of proposed and actual changes in Federal and State policy that have the potential to affect the 340B program, we conducted a rapid response study, exploring the impact to facilities that serve people living with or at risk for HIV. As a companion to the Navigating 340B Toolkit, this Explainer takes a closer look at the answers to these three questions: 1. How does 340B work? 2. What is the relationship between 340B and HIV services? 3. What are the current factors impacting 340B revenue for HIV clinical and service organizations?

Read More
Substance Use
Navigating 340B amidst policy changes: an explainer

October 4, 2024

Drug checking services can prevent overdose by providing people who use drugs (PWUD) with an opportunity to understand the chemical content of their drugs. In this brief report, we share perspectives from clients of drug checking services in the San Francisco Bay Area. Participants described how drug checking provided a way of monitoring contaminants, promoted entry into other harm reduction services, and reduced likelihood of overdose.

Read More
Substance Use
Client Perspectives on Drug Checking Services for Overdose Prevention

April 9, 2024